Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Objective: To summarize the literature investigating changes in emotional expression (EE) as a function of pharmacotherapy in the treatment of ADHD and to differentiate emotional effects related to ADHD pharmacotherapy from emotional effects related to ADHD as a disorder. Method: English language articles published from January 1, 1988, through August 31, 2008 were identified through a PubMed literature search using the search terms attention, ADHD, hyperactive, hyperkinesis, and ADD cross-referenced with medication terms amphetamine, lisdexamfetamine, methylphenidate , guanfacine, atomoxetine, and clonidine. The search was limited to randomized, controlled trials. Abstracts from all identified articles were selected for further review if they met criteria including (a) presence of a placebo arm, (b) children ≤18 years of age, (c) ≥20 participants, and (b) study design elements that would allow reviewers to determine whether EE phenomena were specifically attributable to medication effects versus alternative explanations (e.g., time, maturation, baseline comorbidity, selection artifacts, or treatments other than the medication-placebo contrast). Qualifying full-text articles were reviewed for prespecified EE terms. Results: Of 148 articles that met selection criteria, 47 reported varying types of EE. Eight of these included two active treatment arms. Hence, 55 data sets were identified. Patterns of change in EE in studies meeting search criteria are discussed. Data sets that reported accounts of EE by the percentage of patients were compiled and further analyzed for specific medication classes. The changes in EE are further discussed as (a) salutary or detrimental, (b) associated with time of day or circumscribed, and (c) presumed to be caused by pharmacological effects. Conclusions: Definitive methodologies for assessing the presence of changes in EE in clinical trials and guidelines for the evaluation of EE in clinical practice are yet to be established and are needed. Such guidelines could be used by clinicians to monitor positive and negative changes in emotion when patients are taking medications for their ADHD. (J. of Att. Dis. 2011; 15(2) 101-112)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, two randomized controlled trials comparing amphetamine against placebo found no beneficial medication impact on a broad range of emotional problems and some studies find amphetamine preparations increase irritability and lability (116).”
From Emotion Dysregulation in Attention Deficit Hyperactivity Disorder (2014) · cites this paper as [116]
In the citing paper
“definitive methodologies for assessing EL changes in practice and clinical trials are as yet unestablished (Manos et al., 2011)”
From A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials (2024) · cites this paper as Manos et al., 2011
Citations
Cites
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · cited 5×
“…Manos, Short, & Findling, 1999; Matza et al., 2004; Mayes, Crites, Bixler, Humphrey, & Mattison, 1994; McCracken et al., 2003; McGough et al., 2005; Michelson et al., 2002; Newcorn et al., 2008; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005; Pelham, Aronoff, et al., 1999; Pelham et al.,…”
BackgroundInfluentialKelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 3×
“…Findling, & Swanson, 2002; Grizenko, Shayan, Polotskaia, Ter-Stepanian, & Joober, 2008; Hinshaw, Buhrmester, & Heller, 1989; James et al., 2001; Kelsey et al., 2004; Klorman, Brumaghim, Fitzpatrick, Borgstedt, & Strauss, 1994; Kratochvil et al., 2007; Manos, Short, & Findling, 1999; Matza et…”
BackgroundBarkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PubMed · Cited by 433
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404
Self-citationBarkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990) · Pediatrics · doi:10.1542/peds.86.2.184 · Cited by 372
Biederman, J., Boellner, S. W., Childress, A., Lopez, F. A., Krishnan, S., & Zhang, Y. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.015 · Cited by 360
Self-citationGillberg, C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210105014 · Cited by 340 · cited 8×
“Three (Ahmann et al., 1993; Gillberg et al., 1997; Short et al., 2004) of these six studies reported EE as a percentage Table 1.”
BackgroundMethodInfluentialNewcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 5×
“…Wigal, et al., 2004, 2006) reported EE in some manner and eight studies (Biederman, Boellner, et al., 2007; Daviss et al., 2008; Manos et al., 1999; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999; Pelham et al., 1990; Pelham, Gnagy, et al., 1999; Pliszka et al., 2000) had two active…”
InfluentialBiederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317 · cited 3×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine…”
BackgroundInfluentialPelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · Pediatrics · doi:10.1542/peds.86.2.226 · Cited by 249 · cited 17×
“…2005; Pelham, Aronoff, et al., 1999) — — +4.8% (Barkley et al., 1990; Daviss et al., 2008; Greenhill et al., 2002; Pelham, BurrowsMaclean et al., 2005; Pelham et al., 1990; Pelham, Manos, et al., 2005; Short et al., 2004) +8.0% (Chacko et al., 2005; Pelham, Aronoff, et al., 1999) Socially…”
BackgroundInfluentialSafety and tolerability of methylphenidate in preschool children with ADHD
WIGAL, T., GREENHILL, L., CHUANG, S., McGOUGH, J., VITIELLO, B., SKROBALA, A., SWANSON, J., WIGAL, S., ABIKOFF, H., KOLLINS, S., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235082.63156.27 · Cited by 242 · cited 3×
“…Burrows-Maclean et al., 2005; Pelham, Gnagy, et al., 1999; Pelham, Manos, et al., 2005; Pliszka et al., 2000) +1.7% (Pelham, Aronoff, et al., 1999; Wigal et al., 2006) — — -3.8% (Barkley et al., 1990; Daviss et al., 2008; Greenhill et al., 2002; Pelham, BurrowsMaclean et al., 2005; Pelham, Gnagy,…”
InfluentialSwanson, J. M., Wigal, S. B., Wigal, T., Sonuga-Barke, E., Greenhill, L. L., Biederman, J., Kollins, S., Nguyen, A. S., DeCory, H. H., Hirshe Dirksen, S. J., et al. (2004) · Pediatrics · doi:10.1542/peds.113.3.e206 · Cited by 238 · cited 3×
“…Borgstedt, & Strauss, 1994; Pelham, Burrows-Maclean et al., 2005; Pelham, Gnagy, et al., 1999; Pelham, Manos, et al., 2005; Pliszka et al., 2000; Swanson et al., 2004) +0.1% (Chacko et al., 2005; Greenhill et al., 2006; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999; Wigal et al., 2006) —…”
InfluentialBehavioral, Situational, and Temporal Effects of Treatment of ADHD With Methylphenidate
SCHACHAR, R. J., TANNOCK, R., CUNNINGHAM, C., & CORKUM, P. V. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00011 · Cited by 216
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G., Nguyen, A., & Waxmonsky, J. (1999) · Pediatrics · doi:10.1542/peds.103.4.e43 · Cited by 196
Greenhill, L. L., Findling, R. L., Swanson, J. M., & MPH MR ADHD Study Group (2002) · PEDIATRICS · doi:10.1542/peds.109.3.e39 · Cited by 185 · cited 8×
“+12% (Pelham, Aronoff, et al., 1999) Irritable, crabby -6.5% (Ahmann et al., 1993; Barkley et al., 1990; Daviss et al., 2008; Firestone et al., 1998; Greenhill et al., 2002; Klorman, Brumaghim, Fitzpatrick, Borgstedt, & Strauss, 1994; Pelham, Burrows-Maclean et al., 2005; Pelham, Gnagy, et al.,…”
InfluentialSelf-citationPlacebo-Controlled Evaluation of Ritalin Side Effects
Ahmann, P. A., Waltonen, S. J., Theye, F. W., Olson, K. A., & Van Erem, A. J. (1993) · Pediatrics · doi:10.1542/peds.91.6.1101 · Cited by 178 · cited 8×
“Of these, two (Ahmann et al., 1993; Short et al., 2004) measured EE using rating scales, and one (Gillberg et al.”
BackgroundMethodInfluentialNewcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00008 · Cited by 174 · cited 1×
“Of the 47 studies that reported EE in some manner, six (Ahmann et al., 1993; Gillberg et al., 1997; Kelsey et al., 2004; Kratochvil et al., 2007; Newcorn et al., 2005; Short et al., 2004) reported base rate, placebo rate, and drug rate.”
BackgroundTransdermal Methylphenidate, Behavioral, and Combined Treatment for Children With ADHD.
Pelham, W. E., Burrows-MacLean, L., Gnagy, E. M., Fabiano, G. A., Coles, E. K., Tresco, K. E., Chacko, A., Wymbs, B. T., Wienke, A. L., Walker, K. S., et al. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.2.111 · Cited by 150
Grizenko, N., Shayan, Y. R., Polotskaia, A., Ter-Stepanian, M., & Joober, R. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0802 · Cited by 140
Pelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., Meichenbaum, D. L., Williams, A., Aronoff, H. R., & Steiner, R. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.1300 · Cited by 138
PLISZKA, S. R., BROWNE, R. G., OLVERA, R. L., & WYNNE, S. K. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200005000-00016 · Cited by 130 · cited 6×
“…Brumaghim, Fitzpatrick, Borgstedt, & Strauss, 1994; Pelham, Burrows-Maclean et al., 2005; Pelham, Gnagy, et al., 1999; Pelham, Manos, et al., 2005; Pliszka et al., 2000; Swanson et al., 2004) +0.1% (Chacko et al., 2005; Greenhill et al., 2006; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999;…”
BackgroundInfluentialDoes stimulant medication improve the peer status of hyperactive children?
Whalen, C. K., Henker, B., Buhrmester, D., & Hinshaw, S. P. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.57.4.545 · Cited by 124 · cited 2×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine & Johnston, 1993; Fi…”
ResultMATZA, L. S., RENTZ, A. M., SECNIK, K., SWENSEN, A. R., REVICKI, D. A., MICHELSON, D., SPENCER, T., NEWCORN, J. H., & KRATOCHVIL, C. J. (2004) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200406000-00005 · Cited by 119 · cited 4×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine & Johnston, 1993; Fi…”
BackgroundInfluentialMCCRACKEN, J. T., BIEDERMAN, J., GREENHILL, L. L., SWANSON, J. M., MCGOUGH, J. J., SPENCER, T. J., POSNER, K., WIGAL, S., PATAKI, C., ZHANG, Y., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046863.56865.fe · Cited by 116 · cited 8×
“8% (McCracken et al., 2003) 0% (Biederman, Boellner, et al.”
InfluentialManos, M. J., Short, E. J., & Findling, R. L. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00010 · Cited by 111 · cited 2×
“…et al., 1989; Wigal, et al., 2004, 2006) reported EE in some manner and eight studies (Biederman, Boellner, et al., 2007; Daviss et al., 2008; Manos et al., 1999; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999; Pelham et al., 1990; Pelham, Gnagy, et al., 1999; Pliszka et al., 2000) had…”
BackgroundResultSelf-citationClonidine for Attention-Deficit/Hyperactivity Disorder: II. ECG Changes and Adverse Events Analysis
Daviss, W. B., Patel, N. C., Robb, A. S., McDermott, M., Bukstein, O. G., Pelham, W. E., Palumbo, D. R., HARRIS, P., & Sallee, F. R. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d9ae4 · Cited by 104 · cited 26×
“…2008) — -1.2% (Biederman et al., 2008) -3.8% (Daviss et al., 2008) — Sad, depressed +12.7% (Daviss et al., 2008) — — — +3.2% (Daviss et al., 2008) — Socially withdrawn +12.8% (Daviss et al., 2008) — — — +9.4% (Daviss et al., 2008) — Affect lability +2.4% (Michelson et al., 2002) — — -11.1%…”
BackgroundResultInfluentialSpencer, T. J., Wilens, T. E., Biederman, J., Weisler, R. H., Read, S. C., & Pratt, R. D. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.011 · Cited by 102 · cited 3×
“…Tannock, Cunningham, & Corkum, 1997; Short, Manos, Findling, & Schubel, 2004; Silva et al., 2006; Smithee, Klorman, Brumaghim, & Borgstedt, 1998; Spencer et al., 2006; Swanson et al., 2004; Whalen et al., 1989; Wigal, et al., 2004, 2006) reported EE in some manner and eight studies (Biederman,…”
InfluentialFIRESTONE, P., MUSTEN, L. M., PISTERMAN, S., MERCER, J., & BENNETT, S. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.13 · Cited by 102 · cited 4×
“…2005; Short et al., 2004) -9.8% (Chacko et al., 2005; Pelham, Aronoff, et al., 1999) Sad, depressed +3.8% (Barkley et al., 1990; Daviss et al., 2008; Firestone et al., 1998; Greenhill et al., 2002; Klorman et al., 1994; Pelham, Burrows-Maclean et al., 2005; Pelham, Manos, et al., 2005; Pliszka et…”
InfluentialWIGAL, S., SWANSON, J. M., FEIFEL, D., SANGAL, R. B., ELIA, J., CASAT, C. D., ZELDIS, J. B., & CONNERS, C. K. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138351.98604.92 · Cited by 101
Findling, R. L., Bukstein, O. G., & Melmed, R. D. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0120 · Cited by 100 · cited 2×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine & Johnston, 1993; Fi…”
Self-citationMcGough, J. J., Biederman, J., Wigal, S. B., López, F. A., McCracken, J. T., Spencer, T. J., Zhang, Y., & Tulloch, S. J. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157550.94702.a2 · Cited by 95 · cited 4×
“…et al., 2007; Manos, Short, & Findling, 1999; Matza et al., 2004; Mayes, Crites, Bixler, Humphrey, & Mattison, 1994; McCracken et al., 2003; McGough et al., 2005; Michelson et al., 2002; Newcorn et al., 2008; Newcorn, Spencer, Biederman, Milton, & Michelson, 2005; Pelham, Aronoff, et al.,…”
BackgroundInfluentialSelf-citationDouble-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD
JAMES, R. S., SHARP, W. S., BASTAIN, T. M., LEE, P. P., WALTER, J. M., CZARNOLEWSKI, M., & CASTELLANOS, F. X. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200111000-00006 · Cited by 92 · cited 2×
“…al., 2006; Greenhill, Findling, & Swanson, 2002; Grizenko, Shayan, Polotskaia, Ter-Stepanian, & Joober, 2008; Hinshaw, Buhrmester, & Heller, 1989; James et al., 2001; Kelsey et al., 2004; Klorman, Brumaghim, Fitzpatrick, Borgstedt, & Strauss, 1994; Kratochvil et al., 2007; Manos, Short, &…”
Biederman, J., Heiligenstein, J. H., Faries, D. E., Galil, N., Dittmann, R., Emslie, G. J., Kratochvil, C. J., Laws, H. F., Schuh, K. J., & Atomoxetine ADHD Study Group (2002) · Pediatrics · doi:10.1542/peds.110.6.e75 · Cited by 87 · cited 4×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine…”
BackgroundInfluentialGau, S. S.-F., Shen, H.-Y., Soong, W.-T., & Gau, C.-S. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.441 · Cited by 77
A Dose-Ranging Study of a Methylphenidate Transdermal System in Children With ADHD
Pelham, W. E., Manos, M. J., Ezzell, C. E., Tresco, K. E., Gnagy, E. M., Hoffman, M. T., Onyango, A. N., Fabiano, G. A., Lopez-Williams, A., Wymbs, B. T., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157548.48960.95 · Cited by 75
Self-citationMETHYLPHENDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS
Mayes, S. D., Crites, D. L., Bixler, E. O., Humphrey, F. J., & Maltison, R. E. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11811.x · Cited by 70
Greenhill, L. L., Muniz, R., BALL, R. R., Levine, A. J., Pestreich, L. K., & Jiang, H. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220847.41027.5d · Cited by 70 · cited 3×
“…et al., 2008; Fine & Johnston, 1993; Firestone, Musten, Pisterman, Mercer, & Bennett, 1998; Gau, Shen, Soong, & Gau, 2006; Gillberg et al., 1997; Greenhill et al., 2006; Greenhill, Findling, & Swanson, 2002; Grizenko, Shayan, Polotskaia, Ter-Stepanian, & Joober, 2008; Hinshaw, Buhrmester, &…”
InfluentialAnger control in response to verbal provocation: Effects of stimulant medication for boys with ADHD
Hinshaw, S. P., Buhrmester, D., & Heller, T. L. (1989) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00915034 · Cited by 69
Chacko, A., Pelham, W., Gnagy, E., Greiner, A. R., Vallano, G., Bukstein, O., & Rancurello, M. (2005) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/00004583-200503000-00009 · Cited by 67 · cited 6×
“…2002; Pelham, BurrowsMaclean et al., 2005; Pelham, Gnagy, et al., 1999; Pelham et al., 1990; Pelham, Manos, et al., 2005; Short et al., 2004) -9.8% (Chacko et al., 2005; Pelham, Aronoff, et al., 1999) Sad, depressed +3.8% (Barkley et al., 1990; Daviss et al., 2008; Firestone et al., 1998;…”
InfluentialAhmann, P. A., Theye, F. W., Berg, R., Linquist, A. J., Van Erem, A. J., & Campbell, L. R. (2001) · Pediatrics · doi:10.1542/peds.107.1.e10 · Cited by 64 · cited 1×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine…”
A Prospective Study of Stimulant Response in Preschool Children: Insights From ROC Analyses
Short, E. J., Manos, M. J., Findling, R. L., & Schubel, E. A. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200403000-00005 · Cited by 55 · cited 11×
“Of these, two (Ahmann et al., 1993; Short et al., 2004) measured EE using rating scales, and one (Gillberg et al.”
BackgroundMethodInfluentialSelf-citationArnold, L. E., Lindsay, R. L., Conners, C. K., Wigal, S. B., Levine, A. J., Johnson, D. E., West, S. A., Sangal, R. B., Bohan, T. P., & Zeldis, J. B. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.542 · Cited by 51 · cited 1×
“Of these, 47 (Ahmann et al., 1993, 2001; Arnold et al., 2004; Barkley, McMurray, Edelbrock, & Robbins, 1990; Biederman, Boellner, et al., 2007; Biederman et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine…”
Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1994) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.103.2.206 · Cited by 46 · cited 2×
“8% (Barkley et al., 1990; Daviss et al., 2008; Firestone et al., 1998; Greenhill et al., 2002; Klorman et al., 1994; Pelham, Burrows-Maclean et al., 2005; Pelham, Manos, et al., 2005; Pliszka et al., 2000) +3.”
InfluentialSilva, R. R., Muniz, R., Pestreich, L., Childress, A., Brams, M., Lopez, F. A., & Wang, J. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.239 · Cited by 44 · cited 3×
“…et al., 2004) +0.1% (Chacko et al., 2005; Greenhill et al., 2006; Newcorn et al., 2008; Pelham, Aronoff, et al., 1999; Wigal et al., 2006) — -5.6% (Silva et al. 2006) -10.7% (Barkley et al., 1990; Daviss et al., 2008; Greenhill et al., 2002; Pelham, BurrowsMaclean et al., 2005; Pelham, Gnagy,…”
InfluentialSelf-citationFine, S. H., & Johnston, C. (1993) · Child Psychiatry & Human Development · doi:10.1007/bf02353715 · Cited by 36 · cited 1×
“…et al., 2002, 2008; Biederman, Krishnan, Zhang, McGough, & Findling, 2007; Chacko et al., 2005; Daviss et al., 2008; Findling et al., 2008; Fine & Johnston, 1993; Firestone, Musten, Pisterman, Mercer, & Bennett, 1998; Gau, Shen, Soong, & Gau, 2006; Gillberg et al., 1997; Greenhill et al.,…”
Kratochvil, C. J., Faries, D., Vaughan, B., Perwien, A., Busner, J., Saylor, K., Kaplan, S., Buermeyer, C., & Swindle, R. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0018 · Cited by 32 · cited 7×
“Importantly, just two studies reported positive changes in EE as a result of medication treatment (Kratochvil et al., 2007; Matza et al., 2004).”
BackgroundMethodInfluentialEmotional Expression in Children Treated With ADHD Medication: Development of a New Measure
Perwien, A. R., Kratochvil, C. J., Faries, D., Vaughan, B., Busner, J., Saylor, K. E., Buermeyer, C. M., Kaplan, S., & Swindle, R. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707306117 · Cited by 25 · cited 1×
“Emotional expression (EE) can be conceptualized as the outward appearance of an individual in terms of affect and expressed emotions that are either positive or negative in nature (Perwien et al., 2008).”
BackgroundSmithee, J. A. F., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1998) · Research on Child and Adolescent Psychopathology · doi:10.1023/a:1022698232481 · Cited by 23
Rapport, M. D., Randall, R., & Moffitt, C. (2002) · Journal of Attention Disorders · doi:10.1177/108705470200600103 · Cited by 15 · cited 1×
“For example, positive EE has been reported as a qualitative effect associated with symptom reduction but not necessarily a direct effect of medicine (Rapport et al., 2002).”
Background
Research works printed but not linked: 3
- Grizenko, N., 2008, Journal of Psychiatry & Neuroscience, 33, 10
- 10.1037/0021-843x.103.2.206 · DOI
- 10.1037/0022-006x.57.4.545 · doi:10.1037/0022-006x.57.4.545 · Paper page
Cited by
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232
“A review found that two randomized placebo-controlled studies in children with ADHD reported that psychostimulants reduced emotional lability and irritability (127).”
Stringaris, A., Vidal‐Ribas, P., Brotman, M. A., & Leibenluft, E. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12823 · Cited by 220
“There is also evidence against the notion that stimulants increase irritability as a side effect (Ahmann et al., 1993; Manos et al., 2011).”
BackgroundFernández de la Cruz, L., Simonoff, E., McGough, J. J., Halperin, J. M., Arnold, L. E., & Stringaris, A. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.006 · Cited by 120
“Two randomized controlled trials comparing amphetamine and placebo found no beneficial effect of the medication on a broad range of emotional problems, and some studies have found that amphetamine preparations increase irritability and lability.(21) On the other hand, it has recently been shown that children with ADHD…”
BackgroundThe Relation of Poor Emotional Awareness and Externalizing Behavior Among Children With ADHD
Factor, P. I., Rosen, P. J., & Reyes, R. A. (2016) · Journal of Attention Disorders · doi:10.1177/1087054713494005 · Cited by 80
“The child’s age, gender, ADHD subtype, and the presence or absence of psychotropic medication were all entered into the first step as covariates; all of these factors have been found to influence emotional expressiveness (Manos et al., 2011).”
BackgroundReimherr, F. W., Marchant, B. K., Gift, T. E., Steans, T. A., & Wender, P. H. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0176-z · Cited by 63
“While the literature broadly supports the importance of emotional symptoms in ADHD, two recent reviews note the absence of consensus as to how emotional dysregulation in ADHD should be defined and how it should be measured (Manos et al. 2011; Shaw et al. 2014).”
Background
Metadata
- Authors
- Manos, M. J., Brams, M., Childress, A. C., Findling, R. L., López, F. A., & Jensen, P. S.
- Affiliations
- Cleveland Clinic (US)
- Baylor College of Medicine (US)
- Center for Psychiatry and Behavioral Medicine (US)
- University Hospitals Cleveland Medical Center (US)
- Children's Developmental Center, Winter Park, FL
- The REACH Institute, New York, NY
- Corresponding author
- Manos, Michael J.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2010-09-28
- Volume
- 15
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2042804959
- Cited by
- 28
- References
- 49
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Attention Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- attention deficit hyperactivity disorder, ADHD medication, emotional expression, amphetamine, lisdexamfetamine, methylphenidate, guanfacine, atomoxetine, clonidine, children, emotion monitoring
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Emotions, Humans, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.